期刊文献+

异质性万古霉素耐药葡萄球菌分离及生物学特性观察 被引量:48

Staphylococcus hetero-resistance to vancomycin:detection and biological characteristics
原文传递
导出
摘要 目的 了解本地区临床标本中异质性万古霉素耐药葡萄球菌 (h VRS)分离率 ,并对其生物学特性进行观察。方法 采用琼脂筛选和菌谱分析法对 5 6株甲氧西林耐药的葡萄球菌进行检测 ,同时对分离细菌的生长特性和超微结构进行观察 ,并与同源性敏感菌株及金黄色葡萄球菌标准菌株相比较。结果 本地区h VRS检出率为 14 .3% ,其中血浆凝固酶阴性葡萄球菌的分离率 (2 3.1% )明显高于金黄色葡萄球菌 (6 .7% ) ;耐药亚群与同源性敏感菌株和标准菌株比较 ,生长速度减慢 ,在固体培养基上菌落大小不等 ,在液体培养基中呈沉淀生长 ,电镜观察可见细胞壁增厚。结论 h VRS在本地区的临床标本中有一定的分离率 ,应引起重视 ;该菌的很多生物学特性与同源性敏感菌株有所不同 ,其中细胞壁增厚是比较明显的改变 ,并与该菌的耐药性有关。 Objective To investigate the prevalence of hetero-resistance of Staphylococcus to vancomycin (h-VRS) and its biological characteristics. Methods 56 strains of methicillin resistant Staphylococcus (MRS) were screened by vancomycin agar plates and confirmed by population analysis profiles. The growing states and ultra-structure of resistant strains were examined and compared with their parent strains and standard strain of S.aureus. Results Of 56 clinica strains of MRS,8 strains were detected as h-VRS,the positive rate was 14.3%,the hetero-resistance to vancomycin in coagulase-negative Staphylococci(h-VRCNS) was more often to be found than in S.aureus(h-VRSA),the positive rates were 23.1% and 6.7% respectively. Comparing with their parent strains,h-VRS showed slower growth and diversity of colony morphology,sedimentation growth in liquid medium,and thicker cell wall. Conclusion There is significantly variation between h-VRS and their parents,the thick cell wall is the most remarkable characteristics,which is responsible for the vancomycin resistance of Staphylococcus.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2004年第7期583-586,共4页 Chinese Journal of Microbiology and Immunology
基金 安徽省"十五"攻关项目基金资助 (0 10 13 0 3 9)
关键词 异质性 万古霉素 耐药性 葡萄球菌 生物学 h-VRS 细胞壁 Staphylococcus Vancomycin Hetero-resistance Cell wall
  • 相关文献

参考文献24

  • 1Biavasco F, Vignaroli C, Lazzarini R, et al. Glycopeptide susceptibility profiles of Staphylococcus haemolyticus bloodstream isolates. Antimicrob Agents Chemother, 2000, 44(11): 3122-3126.
  • 2CDC. Staphylococcus aureus resistant to Vancomycin-United States,2002. Morb Mortal Wkly Rep, 2002, 51(26): 565-567.
  • 3CDC. Public Health Dispatch: Vancoomycin-Resistant Staphylococcus aureusPennsylvania, 2002. Morb Mortal Wkly Rep, 2, 2002, 51(40): 902.
  • 4Hiramatsu K, Hanaki H, Ino T, et al. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother, 1997, 40(1): 135-136.
  • 5Hiramatsu K, Aritaka N, Hanaki H, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet, 1997, 350(12): 1670-1673.
  • 6Sieradzki K, Villari P, Tomasz A. Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of Staphylococci. Antimicrob Agents Chemother, 1998, 42(1):100-107.
  • 7Marchese A, Balistreri G, Tonoli E, et al. Heterogeneous vancomycin resistance in mehthiillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital . J Clin Microbiol, 2000, 38(2): 866-869.
  • 8Poly MC, Grelaud C, Martin C, et al. First clinical isolate of vancomycin-intermediate Stsaphylococcus in a French hospital. Lancet, 1998,351: 1212.
  • 9Viedma DG, Rabadan PM, Diaz M, et al. Heterogeneous antimicrobial resistance patterns in polyclonal populations of coagulase-negative Staphylococcus isolated from catheters. J Clin Microbiol, 2000, 38(4): 1359-1363.
  • 10Wong SSY, Ho PL, Woo PCY, et al. Bacteremia caused by staphylococci with inducible vancomycin heteroresistance. Clin Infect Dis, 1999,29: 760-767.

二级参考文献14

  • 1李家泰,魏瑾.甲氧西林耐药金葡菌(MRSA)感染的诊断与治疗[J].中国临床药理学杂志,1993,9(2):97-108. 被引量:24
  • 2魏瑾,李家泰.多聚酶链反应(PCR)技术在甲氧西林耐药金葡菌检测中的应用[J].中国临床药理学杂志,1994,10(1):42-49. 被引量:2
  • 3[1]Tosaka M, Yamane N, Okabe H. Isolation and antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus(MRSA) at Kumamoto University hospital[J]. Nippon Rinsbo, 1992, 50(5): 975.
  • 4[2]Cox RA, Conquest C, Mallaghan C, et al. A major outbreak of methicillin-resistant Staphylococcus aureus by a new phagetype(EMRSA-16)[J]. J Hosp Infect, 1995, 29: 87.
  • 5Hiramatsu K, Aritaka N, Hanaki H, et al Dissemination in Japanese hospital of strains of Staphylococcus aureus heterogeneously resistant to vancomycin [J]. The Lancet,1997 ; 350(12): 1670
  • 6Hanaki H, Inaba Y, Sasaki K, et al. A novel method of detecting Staphylococcus aureus heterogeneously resistant to vancomycin [J]. Jpn J Antibiot, 1998; 521 (21): 51
  • 7Shopsin B, Mathema B, Martinez J, et al. Prevalence of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in the community [J]. J Infect Dis,2000;182:359
  • 8Biavasco F, Vignaroli C, Lazzarini R, et al. Glycopeptide susceptibility profiles of Staphylococcus haemolyticus booodstream isolates [J]. Antimicrob Agents Chemother.2000; 44 (11): 3122
  • 9Markowitz N, Quinn E L, Saravolatz L D. Trimethoprim sulfamethoxazole compared with vancomycin for treatment of Staphylococcus aureus infection [J]. Ann Intern Med,1992;117:390
  • 10Tamer M A, Bray J D. Trimethoprim sulfamethoxazole treatment of mulit-ant ibiotic-resistan t staphylococcal endocarditis and meningitis [J]. Clin Pediatr, 1986; 21:125

共引文献441

同被引文献574

引证文献48

二级引证文献211

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部